Published 1994 | Version v1
Journal article

Enhanced erythropoietin and suppression of γ-glutamyl trans-peptidase (GGT) activity in murine lymphoma following administration of vanadium

  • 1. Division of Biochemistry, Department of Pharmaceutical Tchnology, Jadavpur University, 700032 Calcutta (India)

Description

Administration of vanadium as ammonium mono-vanadate (0.005 μg/0.1 ml/mouse/day) was found to reduce the tumor cell proliferation in the host mice bearing Dalton's lymphoma. The high activity of γ-glutamyl trans-peptidase (CCT), a neoplastic marker, was seen in the host cells bearing lymphoma. Vanadium effectively prevented an increase in activity of γ-glutamyl trans-peptidase and maintained a sustained low activity of this enzyme. In addition, an improvement of the hematological aspects of the mice and almost fourfold elevation of erythropoietin (Epo) was obtained following vanadium treatment. This in Epo activity may play a vital role in regulating the growth of cellular neoplasia. The present study further confirms the anti-tumorigenic potential of vanadium in the control of tumor progression in lymphoma via modulating several factors involving erythropoiesis and may emerge as a new chemo-preventive agent for the future. (author)

Additional details

Publishing Information

Journal Title
Neoplasma
Journal Volume
41
Journal Issue
5
Journal Page Range
p. 291-296
ISSN
0028-2685

Optional Information

Notes
2 figs., 2 tabs., 36 refs.